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DENDRITIC TOPOLOGY OF D1 AND D2 MEDIUM SPINY NEURONS IN THE 
Q-175 MOUSE MODEL OF HUNTINGTON’S DISEASE 
ANASTASIA RUBAKOVIC 
ABSTRACT 
 Direct (D1) and indirect (D2) pathway medium spiny neurons (MSNs) in the 
striatum are severely affected in Huntington’s disease. The aim of this study was to 
compare the dendritic topology and electrophysiological properties of wild type (WT) D1 
and D2 MSNs with those in the Q-175 mouse model of Huntington’s disease. By 
scanning biocytin-filled MSNs using high-resolution confocal imaging, we quantified the 
dendritic lengths and complexity of WT and Q-175+/- D1 and D2 MSNs. We correlated 
these dendritic topological parameters with various electrophysiological properties. 
Q175+/- D1 MSNs had significantly larger total dendritic lengths, more complex 
dendritic arbors, and a larger mean number of primary dendrites than their WT 
counterparts. Q175+/- D2 MSNs had similar total dendritic lengths, dendritic 
complexities, and mean number of primary branches as the WT D2 MSNs. WT D1 and 
D2 MSNs were similar in terms of their total dendritic length, total number of 
intersections, and mean number of primary dendrites suggesting a degree of homogeneity 
in these cell populations. We found no correlations between membrane resistance, 
rheobase, EPSC frequency, or EPSC amplitude, and total dendritic length or dendritic 
complexity of MSNs when observed separately (WT and Q175+/-) or combined, with 
one exception, a positive correlation between rheobase and total intersections. These 
findings add to the understanding of the morphology of D1 and D2 MSNs in general, as 
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well as how they are differentially affected by the presence of a CAG expansion in the Q-
175+/- mouse model of Huntington’s disease.  
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INTRODUCTION 
Huntington’s Disease Demographics 
Huntington’s disease is a neurodegenerative disorder that is characterized by 
abnormalities in movement, mood, and cognition (Raymond, 2016). The symptoms 
largely manifest during middle age, however juvenile (<20 years) and elder (>70 years) 
onset can occur (Novak & Tabrizi, 2011). The disease affects males and females at an 
equal frequency (Reiner et al, 2011). Interestingly, the incidence of the disease varies 
based on region of the world. It tends to be much more prevalent in Western populations, 
affecting between 10-13 people in 100,000. Meanwhile it is much less significant in 
Asian and African populations (Vonsattel & Difiglia, 1998).  
Huntington’s disease is inherited in an autosomal dominant fashion and is caused by a 
mutation in the huntingtin gene, also known as the IT15 gene. The IT15 gene is situated 
on chromosome 4 and codes for the huntingtin (Htt) protein, which is crucial for normal 
neural development (Novak & Tabrizi, 2011). The mutation causes an expansion of CAG 
trinucleotide repeats, which leads to the production of a defective Htt protein with a 
mutant polyglutamine section near the N terminus. Accumulation of the defective Htt 
protein ultimately results in neurodegeneration.  
A typical Huntington gene has fewer than 35 CAG trinucleotide repeats. A gene with 
trinucleotide expansions larger than 35 is considered abnormal and typically leads to the 
manifestation of the disease (Menalled et al, 2012). The average repeat length in 
individuals diagnosed with Huntington’s disease is 44 (Reiner et al, 2011). Moreover, the 
repeat length and age of onset are inversely correlated (Figure 1). The greater the number 
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of CAG repeats, the earlier the age of onset of the disorder (Langbehn et al, 2010). A 
diagnosis of Huntington’s disease is definitive based on the presence of this mutation. A 
highly specific genetic test has been developed, which allows pre-clinical diagnosis years 
before the motor symptoms even become present (Walker, 2007).  
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Figure 1: Graphical representation of the relationship between CAG repeats and 
age of onset of Huntington’s disease. Reiner and colleagues concluded that there was an 
overall inverse relationship between the length of CAG repeat expansions and age of 
onset. Generally, the larger the number of CAG repeat expansions, the earlier the disease 
manifested in patients. This trend seems to be true for adult onset HD, however it may 
not be the case in juvenile onset (<20 years, highlighted in green and yellow). Increasing 
CAG repeats does not significantly advance the age of onset of the disease. The pale pink 
box highlights the uncharacteristic adult onset cases with greater than 60 CAG 
expansions typically linked to juvenile onset (Modified from: Reiner et al, 2011).  
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Clinical Symptoms of Huntington’s Disease  
Huntington’s disease is a disorder that progresses gradually with symptoms usually 
becoming present in an individual’s fourth decade of life (Novak & Tabrizi, 2011). It is 
characterized by motor, cognitive, and mood symptoms. Individuals generally develop 
cognitive and psychiatric symptoms before motor symptoms are detected. The mood 
disorders that commonly manifest include depression, anxiety, and psychosis (Epping et 
al, 2016). In the early stages of the disease, the motor symptoms manifest as erratic, 
involuntary movements called chorea, while the later stages are characterized by 
bradykinesia and an inability to initiate purposeful movement (Galvan et al, 2012). The 
cognitive symptoms include difficulties in frontal executive function, such as planning, 
multi-tasking, and control of emotions and behavior. In addition, individuals also 
experience memory loss, dementia, and impairments in skilled learning (Novak & 
Tabrizi, 2011). Moreover, other symptoms include problems with speech, swallowing, 
and balance (Raymond, 2016). Finally, weight loss is commonly observed in patients 
affected by the disease (Wang & Qin, 2006). Approximately 15-20 years following motor 
diagnosis, the disease eventually leads to death (Novak & Tabrizi, 2011).  
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Figure 2: The course of Huntington’s disease over a patient’s lifespan. Novak and 
Tabrizi overlaid the progression of both clinical and neurological symptoms of the 
disease. Neurobiological changes occur years before motor symptoms can be detected. 
Chorea is usually the earliest motor symptom noted, followed by motor impairment or 
bradykinesia. Neuronal dysfunction seems to play a role earlier in the disease course, 
however neuronal cell death in susceptible regions of the brain becomes predominant and 
likely correlated to motor impairment and functional disability (Modified from: Novak & 
Tabrizi, 2011).    
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Striatum 
The striatum is a component of the basal ganglia, and is comprised of the caudate 
putamen and nucleus accumbens (Heikkinen, 2012) (Figure 3). It consists of the dorsal 
and ventral striatum, and is a major site of dopaminergic innervation (Moyer et al, 2007). 
Medium spiny neurons (MSNs) comprise 90-95% of the cells in the striatum and receive 
abundant glutamatergic input from cortical neurons, dopaminergic cells from the 
substantia nigra, local circuit neurons, as well as the intralaminar nuclei of the thalamus 
(Purves et al, 2001). Direct pathway MSNs send projections to the substantia nigra pars 
reticulata (SNpr) and the globus pallidus pars interna (GPi) (Figure 4). Since MSNs use 
GABA as their neurotransmitter, they inhibit the cells in these regions, which are also 
GABAergic. Thus, there is an ultimate disinhibition of thalamic glutamatergic neurons, 
which receive input from the SNpr/GPi and send projections to the cortex (Calabresi et 
al, 2014). Indirect pathway MSNs also project to the SNpr, however they take a 
secondary route via the globus pallidus externa (GPe) and the subthalamic nucleus (STN) 
(Figure 4). These MSNs inhibit GABAergic neurons in the GPe, ultimately disinhibiting 
the glutamatergic neurons of the STN. The STN neurons subsequently stimulate the 
SNpr/GPi GABAergic neurons, which project to and, in turn, inhibit the thalamus 
(Calabresi et al, 2014). Ultimately, the striatum is known to be a point of convergence for 
cortical and thalamic excitatory signals and has influence over a variety of psychomotor 
behaviors (Gertler et al, 2008).  
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Figure 3: Illustration of the components of the Basal Ganglia in relation to other 
brain regions. The basal ganglia consists of several subcortical nuclei. The main 
components include the striatum, both dorsal striatum (caudate nucleus and putamen), 
and ventral striatum (nucleus accumbens and olfactory tubercle), globus pallidus, ventral 
pallidum, substantia nigra, and subthalamic nucleus (Modified from: Joseph, 
brainmind.com).  
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The basal ganglia are primarily innervated by afferent signals coming from the 
cortex and thalamus via glutamatergic corticostriatal and thalamostriatal pathways. The 
striatum is the principle target of these excitatory inputs, mainly innervating the MSNs 
present in this region of the brain (Huerta-Ocampo et al, 2014). The corticostriatal system 
is the major driver of the striatum and the basal ganglia as a whole. While, the 
thalamostriatal system delivers ascending sensory information and is necessary for 
expression of basal ganglia function (Huerta-Ocampo et al, 2014). The primary role of 
the striatum, specifically MSNs, is to coalesce all the cortical and thalamic projections 
and ultimately regulate the output of the striatum. By doing so, they govern the activity of 
other basal ganglia structures, which ultimately control behavior (Huerta-Ocampo et al, 
2014).  
The Direct and Indirect Pathways 
 The basal ganglia processes signals via two distinct pathways, the direct pathway 
and the indirect pathway (Figure 4). These two pathways have opposing net effects on 
their target structures in the thalamus (Knierim, Chapter 4). Exciting the direct pathway 
leads to excitation of thalamic neurons, which has the net effect of exciting motor cortex 
neurons. Meanwhile, exciting the indirect pathway leads to inhibition of thalamic 
neurons, thus not allowing them to excite motor cortex neurons (Knierim, Chapter 4). 
Disturbing the balance of these opposing pathways results in motor dysfunctions.  
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Figure 4: Illustration of the direct and indirect pathways. The solid lines represent the 
direct pathway, and the dashed lines represent the indirect pathway (Modified from: 
Knierim, Chapter 4).  
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 The direct pathway begins with neurons in the striatum, which send inhibitory 
processes to cells in the internal segment of the Globus Pallidus (GPi) and Substantia 
nigra pars reticulate (SNpr). In turn, the GPi/SNpr cells send inhibitory processes to the 
cells of the thalamus (Knierim, Chapter 4). Thus, excitation of direct pathway striatal 
neurons leads to a double inhibition, which ultimately results in a net excitation of the 
motor cortex.  
 On the other hand, the indirect pathway begins with a distinctive faction of striatal 
neurons. These cells send inhibitory projections to the external segment of the Globus 
Pallidus (GPe) (Knierim, Chapter 4). The GPe neurons then send inhibitory processes to 
the cells in the subthalamic nucleus, which subsequently excite the cells in the GPi/SNpr 
(Knierim, Chapter 4). Recall, that the GPi/SNpr cells send inhibitory projections to the 
cells of the thalamus. Thus, activating the GPi/SNpr cells results in inhibition of thalamic 
neurons, and ultimately inhibits the motor cortex.   
Neuronal Structure and Function 
The nervous system is made up of cells called neurons. The human brain consists 
of close to 100 billion neurons (Coon, 2014). Each neuron is made up of a cell body, 
which contains a nucleus. Protruding from the cell body are structures called dendrites 
and a single axon, which are the communicating components of the neuron (Figure 5). 
Dendrites receive signals from axon terminals (boutons) of other neurons and carry them 
to the cell body; meanwhile axons carry information away from the cell body (Coon, 
2014). Axons differ from dendrites in many respects, such as shape, length, and function. 
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Moreover, neurons communicate via an all-or-none electrical signal – the action potential 
(AP) – that travel down a neuron’s axon. Once the electrical signal reaches the end of the 
axon it is converted into a chemical signal and the axon subsequently releases chemical 
messengers called neurotransmitters ("Dendrites - National Library of Medicine - 
PubMed Health"). 
In order for a neuron to reach the action potential threshold and become 
depolarized, it is necessary to integrate many synaptic responses, as individual responses 
are inadequate (Gulledge et al, 2004). Synaptic integration refers to the manner by which 
synaptic responses cooperate to promote or inhibit action potential generation, and 
provides neurons with substantial computational abilities (Gulledge et al, 2004). Action 
potentials spread through dendrites; however, their voltage signal diminishes as they 
propagate within the dendritic tree due to synaptic currents gradually escaping (Gulledge 
et al, 2004). 
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Figure 5: Illustration of the main components of a neuron ("Dendrites - National 
Library of Medicine - PubMed Health"). 
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 Furthermore, dendrites are the main point of localization for inputs into neurons, 
and most neurons have extensive dendritic arbors that receive tens of thousands of 
excitatory and inhibitory synaptic inputs (Urbanska et al, 2008; Gulledge et al, 2004). 
Each neuron type has a distinct pattern of dendritic branching, which affects signal 
integration from neighboring neurons (Gulledge et al, 2004). There is a strong correlation 
between dendritic morphology and a neuron’s function. Therefore, dendrites play a 
critical role in the operation of the nervous system as malformation of neuronal dendrites 
leads to impaired function of the nervous system (Tavosanis, 2011).  
 Many types of neurons, including medium spiny neurons have small, specialized 
structures called spines, which protrude from the dendritic shaft (Koch and Zador, 1993). 
They make up the postsynaptic portion, are the chief targets of excitatory synapses within 
the brain, and receive inputs from glutamatergic axons (Rasia-Filho et al, 2016; Xu et al, 
2014). There are 3 morphological types of spines characterized by their shape: thin, 
stubby, and mushroom (Koch and Zador, 1993). Additionally, there are also dendritic 
filipodia present on the shafts, which receive synaptic input and develop into mature 
spines (Luebke et al, 2010).  
 Dopaminergic terminals projecting from the substantia nigra, as well as 
glutamatergic terminals projecting from the cortex and thalamus, mainly make contact 
with MSN dendritic shafts and spines (Xu et al, 2012). Together, they facilitate the 
functions of the basal ganglia. Thus, MSN dendritic alterations may disturb spine inputs 
and ultimately affect the function of the basal ganglia.  
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Neuropathological Features of Huntington’s Disease  
 The neuropathological features of Huntington’s disease include severe loss of 
medium spiny neurons (MSNs) in the striatum, degeneration of various regions of the 
cortex, enlargement of the ventricles, and diffuse loss of volume of both the striatum and 
cortex (Heikkinen et al, 2012) (Figure 6). The huntingtin (Htt) protein is mainly 
expressed in neurons, but also present in many tissues throughout the body. Initially, 
mutation of the Htt protein predominantly affects GABAergic MSNs located in the 
striatal part of the basal ganglia, specifically in the caudate and putamen nuclei (Vonsattel 
& Difiglia, 1998). Although the striatum is the most profoundly affected region in 
Huntington’s disease, neuronal loss may also be observed in other structures of the basal 
ganglia circuitry such as the cortex, thalamus, zona reticulata of the substantia nigra, and 
superior olive (Wang & Qin, 2006). 
Huntington’s disease presents with widespread atrophy of grey matter in many 
regions of the brain. The neuropathological hallmark of the disease is the selective loss of 
striatal medium spiny neurons and the development of astrogliosis (Menalled, 2005). 
Since MSNs in the striatum are subject to large amounts of glutamatergic input from both 
the cortex and thalamus, it is hypothesized that these excitatory synapses may play a role 
in triggering early disturbances in synaptic plasticity that ultimately leads to neuronal 
degradation (Raymond, 2016). Although the striatum as a whole experiences an 
enormous loss of MSNs, it is apparent that neuronal damage progresses from dorsal to 
ventral regions and thus some MSNs are preferentially susceptible to degeneration 
(Galvan et al, 2012). The MSNs in the striatum that express D2 dopamine receptors and 
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send projections via the indirect pathway to inhibit cortical excitation are the first to 
demonstrate dysfunction and degradation (Glass et al, 2000). This is speculated to be the 
cause of the early stages of motor dysfunction, as indirect pathway MSNs are responsible 
for inhibiting contextually inappropriate movements (Plotkin & Surmeier, 2015). 
Meanwhile, the bradykinesia seen later in the disease is caused by the subsequent 
dysfunction of direct pathway MSNs, which are responsible for promoting contextually 
appropriate movements (Plotkin & Surmeier, 2015). Thus, the neuropathology in 
Huntington’s disease parallels the progressive dysfunction of the circuitry in the striatum.   
Interestingly, some Htt protein aggregates in Huntington’s disease affected brains 
have an amyloid-like structure, similar to those seen in amyloid-associated diseases such 
as Alzheimer’s and prion disease, suggesting possible similarities in the neuropathology 
of these diseases (Mcgowan et al, 2000). Aggregates within the nucleus of neurons, also 
known as neuronal intranuclear inclusions (NIIs), have been detected in Huntington’s 
brains (Reiner et al, 2011). It has been hypothesized that these aggregates lead to 
neuronal death, however the mechanism is still not known. It is possible that the 
huntingtin mutant aggregates are pathogenic due to their ability to sequester fundamental 
proteins such as the TATA- binding transcription factor (Roon-Mom et al, 2002). In 
addition, there is also evidence that these mutant aggregates have the ability to sequester 
and essentially inactivate even normal huntingtin protein. This interferes with the 
production of brain-derived neurotrophic factor (BDNF), which supports the growth and 
survival of neurons (Reiner et al, 2011). However, although the striatum is the most 
affected region in the early stages of Huntington’s disease, studies show that NIIs are 
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mostly absent in the striatum of affected brains. Instead the striatum as well as the cortex 
tend to accumulate neuropil aggregates in neuronal spines, dendrites, and axons. These 
most likely disrupt corticostrial communication (Gutekunst et al, 1999).  
Other areas of the brain including the globus pallidus (GP), thalamus, 
hypothalamus, subthalamic nucleus, substantia niagra (SN), and cerebellum are also 
affected, predominantly during the later stages of the disease (Galvan et al, 2012). In 
addition, the cerebral cortex experiences laminar degradation as well as loss of white 
matter. However, striatal interneurons are relatively unaffected by Huntington’s disease 
(Galvan et al, 2012).  
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Figure 6: Illustration of a normal brain versus an advanced HD stage brain. Coronal 
slice through human telencephalon. Illustrating a normal brain on the right, and advanced 
HD stage brain on the left with severely diminished cortex and caudate resulting in 
ventricular enlargement (Modified from: Reiner et al, 2011).  
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Knock-In Mouse Model of Huntington’s Disease 
 A number of mouse models have been created in order to study the progression 
and pathology of Huntington’s disease. The model that most closely mimics the human 
disorder is the knock-in mouse model. These animals display a gradual progression of the 
disease accompanied by early disruptions in behavior as well as molecular and 
neuropathological aberrations (Menalled, 2005). Thus, making them critical in 
understanding the early pathological irregularities caused by the mutation. Knock-in (KI) 
mouse models have the expanded CAG repeat mutation inserted into their endogenous 
huntingtin gene rather than randomly inserted into the genome like in transgenic mouse 
models.  Therefore, KI mice most accurately mimic the genetics of the human disorder 
(Menalled, 2005).  
The zQ175 Knock-In Mouse Model of Huntington’s Disease 
The specific mouse model of Huntington’s disease used in this study was the zQ175 
knock-in model. It closely resembles the human condition on several accounts. For 
example, electrophysiological recordings were used to determine that the MSNs in these 
animals demonstrated a gradual hyperexcitability (Heikkinen et al, 2012). Furthermore, 
zQ175 MSNs exhibited an increased input resistance (Indersmitten et al, 2015). Finally, 
the MSNs displayed a decreased frequency of spontaneous excitatory postsynaptic 
currents (sEPSCs), however no observed changes in sEPSC amplitudes (Indersmitten et 
al, 2015).  
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In addition, the glutamatergic conduction in the striatum was greatly diminished and 
in vivo structural MRI scans were used to determine that the zQ175 mice exhibited 
substantial atrophy of the striatum and cortex even before motor symptoms were 
detected, which can also be seen in HD patients (Heikkinen et al, 2012; Peng et al, 2016). 
Finally, mutant Htt aggregates were found throughout the striatum and cortex of zQ175 
mice and the number of aggregates increased with age (Peng et al, 2016).   
The mice underwent several behavioral tests in order to assess impairment in motor 
and cognitive function (Heikkinen et al, 2012). An open field test determined that the 
animals travelled progressively shorter distances from 2-12 months of age suggesting 
deficiency in motor function. In addition, a rearing-climbing test was conducted in which 
the animals were placed in wired pencil holder. It was observed that the mice gradually 
tended to climb less from 2-12 months of age. Finally, a swim test was administered in 
which the mice were placed in water in order to determine if they were able to properly 
swim to a platform. The animals illustrated an impaired ability to correctly swim to the 
platform, demonstrating a deficit in procedural memory, which is one of the functions of 
the striatum.  
Moreover, it was also observed that zQ175 mice experienced a reduction in body 
weight, which can also be seen in humans with Huntington’s disease (Heikkinen et al, 
2012). However, the zQ175 mouse model does not mimic the human condition on all 
parameters. It is not clear why, but the zQ175 mouse model lacks the initial hyperkinetic 
phase characterized by chorea that is observed in humans (Plotkin & Surmeier, 2015). 
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Thus, the zQ175 mouse model of Huntington’s disease quite closely mimics the human 
condition, but not on all accounts.  
D1 v D2 Medium Spiny Neurons 
MSNs are named for their medium-sized cell body. Their dendrites are initially 
aspinous and then become heavily populated with spines as you move distally from the 
cell body (Huerta-Ocampo et al, 2014). The striatal output is principally separated into 
two distinct cell populations of MSNs, the direct (D1) and indirect (D2) pathway MSNs. 
The D1 and D2 MSNs receive input signals specifically from the cortex and thalamus, 
which synapse on their spines. The cortical input was found to be greater than the 
thalamic for both the direct and indirect pathway MSNs (Huerta-Ocampo et al, 2014). 
MSNs in the direct pathway primarily express D1 Dopamine receptors in addition to 
substance P and dynorphin and send projections to the SN pars reticulata (SNPr) and the 
internal segment of the GP (GPi) (Galvan et al, 2012). Meanwhile, MSNs that belong to 
the indirect pathway principally express D2 Dopamine receptors and mentenkephalin, 
and send projections to the external segment of the GP (GPe) (Galvan et al, 2012). 
Despite these differences in axonal projections, D1 and D2 MSNs have generally been 
considered homogenous in terms of their morphological and physiological properties 
(Gertler et al, 2008).  
However, the homogeneity of direct and indirect pathway MSNs has been challenged, 
as the findings from several studies have been inconsistent. Some argue that the 
differences between these two pathways are important in regards to the progression of 
Huntington’s disease, as the unique morphologies of the two cell populations lead to 
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distinctive time-dependent alterations (Galvan et al, 2012). A study done by Gertler and 
colleagues found several morphological and physiological differences between direct and 
indirect pathway MSNs (Figure 7). For example, D1 MSNs had reduced excitability 
compared to D2 MSNs. In addition, 3D reconstruction of the MSNs was used to 
demonstrate that D1 MSNs had a larger total dendritic length than D2 MSNs, as well as a 
higher number of primary dendrites. Furthermore, a 3D sholl analysis concluded that D1 
MSNs had a greater number of intersection between 10 and 135um away from the soma 
compared to D2 MSNs. Finally, a convex hull analysis determined that D1 MSNs 
occupied a greater amount of 3D space than D2 MSNs. Thus, there is evidence 
suggesting that striatal MSNs are not only distinct in their intrinsic physiology, but also 
in their morphological features. Gertler et al concluded that D1 and D2 striatal MSNs are 
not homogenous, but instead have rather distinct somatodendritic properties that lead to 
differences in their intrinsic excitability.  
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Figure 7: Analysis of anatomical differences between reconstructed D1 and 
D2 MSNs. Results found by the aforementioned Gertler et al study. a. 3D Sholl analysis 
of biocytin-filled and reconstructed neurons from P35-45 BAC transgenic mice. D1 
MSNs display a more complex dendritic arbor as represented by the increased number of 
intersections. b. The mean dendritic length between D1 and D2 MSNs was not 
significantly different. c. Whole-cell capacitance is positively correlated to total dendritic 
length. d. D1 MSNs demonstrate a significantly higher number of primary dendrites, 
branch points, tips, and total dendritic length (Modified from: Gertler et al, 2008).  
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 On the other hand, a subsequent study performed by Huerta-Ocampo and colleagues 
argued that there are no morphological differences between the two cell populations. The 
study found no observed distinctions in the number of primary dendrites or high-order 
dendrites. In addition, unlike the results found by Gertler and colleagues, they discovered 
no differences in the average length of dendrites of various order, the total dendritic 
lengths, as well as the preferred orientation of their dendritic trees (Huerta-Ocampo et al, 
2014).  Finally, there were no observed differences in the number of intersections 
between the two types of MSNs, as was seen in the Gertler et al study (Huerta-Ocampo et 
al, 2014). Thus, the current literature is quite controversial, proposing opposing positions 
regarding the homogeneity of D1 and D2 MSNs.  
Characteristics of D1 and D2 HD-affected Neurons 
The current use of enhanced green fluorescent protein (EGFP) gene has made 
identifying dopamine D1 and D2 receptor-expressing MSNs and examining their 
individual functions a possibility. Mouse models expressing the EGFP gene were used to 
demonstrate that D2 indirect pathway MSNs are especially vulnerable during the early 
stages of Huntington’s disease, as these cells tend to be lost first (Galvan et al, 2012). In 
comparison, D1 direct pathway MSNs tend to be unaffected during the initial progression 
of the disorder. This supports the argument that the initial chorea observed in 
Huntington’s disease patients is due to the loss of indirect pathway (D2) MSNs, and the 
akinesia and dystonia that occurs later in the disease are the result of loss of direct 
pathway (D1) MSNs (Galvan et al, 2012).  
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Moreover, the study found that the terminals that were in contact with direct 
pathway MSNs were considerably smaller than those interacting with indirect pathway 
MSNs (Galvan et al, 2012). Because of the size difference, indirect pathway MSNs 
experience larger amount of glutamate release from corticostriatal terminals, which could 
lead to toxic levels of excitation. In addition, it is possible that indirect pathway MSNs 
may be more excitable, as spontaneous excitatory postsynaptic currents (sEPSCs) occur 
at a higher frequency and large-amplitude excitatory events exclusively occur in these 
MSNs. Finally, indirect pathway MSNs are prone to atypical glutamate release as well as 
dopamine receptor dysfunction, all of which may contribute to the neurodegeneration 
seen in Huntington’s disease (Galvan et al, 2012).  
Purpose of the Study 
The purpose of this study is to not only characterize both the electrophysiological 
and morphological dendritic properties of wild type (WT) D1 and D2 MSNs, but also 
observe any changes that develop in the Q175 +/- knock-in mouse model of Huntington’s 
disease. Previous studies have used transgenic mouse models in order to study 
electrophysiological and morphological properties of WT D1 and D2 MSNs (Gertler et 
al, 2008; Huerta-Ocampo et al, 2014). In addition, studies have also been done observing 
the electrophysiological properties of direct and indirect pathway MSNs in two HD 
mouse models, YAC128 and BACHD (Galvan et al, 2012). However, in Q175+/- mouse 
models of Huntington’s disease, electrophysiology and morphological properties of 
MSNs were studied as a whole, without teasing apart D1 and D2 MSNs (Indersmitten et 
al, 2015). Given the potential evidence for the argument that D1 and D2 MSNs are not in 
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fact homogenous cell populations, but have differential electrophysiological and 
morphological properties of D1 and D2 MSNs, it is important to consider these two cell 
populations independently. Thus, our study takes a step further from the aforementioned 
work on the Q175+/- mouse model, and considers how the electrophysiology and 
morphology of direct and indirect MSNs, respectively, are affected in Q175+/- mice. The 
Q175+/- knock-in mouse model, unlike the transgenic mouse models used in previous 
studies, contains a mutated CAG expansion specifically located within the endogenous 
huntingtin gene, thus making it the most faithful model of the human disease condition 
from a genetic standpoint (Peng et al, 2016). This project will begin to reveal the specific 
dendritic morphology and electrophysiology of the direct and indirect pathway MSNs, 
adding to the understanding of their differential functions and how they are uniquely 
affected in Huntington’s disease. Finally, the study of dendritic topology is important as 
it has many implications in the degree of synaptic integration as well as the consequent 
neural firing behavior of these neurons (Cuntz et al, 2007). 
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MATERALS AND METHODS 
Experimental subjects 
Brain slices from 45 mice (23 female, 22 male; 1 year old) were used in this study 
(9 D1+eGFP x Wild Type, 10 D1+eGFP x Q175+/-, 3 D2-eGFP x Wild Type, 23 D2-
eGFP x Q175+/-). The animals were obtained from the Jackson Laboratory (Ann Arbor, 
ME). All animal work was conducted in adherence to the Institutional Animal Care and 
Use Committee (IACUC) guidelines. All research was conducted in strict adherence to 
animal care guidelines from the NIH Guide for the Care and Use of Laboratory Animals 
and the U.S. Public Health Service Policy on Humane Care and Use of Laboratory 
Animals.  
Preparation of striatal slices 
Mice were anesthetized with Isoflurane (IsoThesia) followed by decapitation. 
Brains were rapidly dissected out and bathed in ice cold Ringer’s Solution (1.24 M NaCl, 
1.0 mM KCl, 2.0 mM KH2PO4, 1.3 mM MgCl2, 2.5 mM CaCl2, 10 mM Glucose). The 
cerebellum and frontal poles were removed prior to slicing. Brains were cut into 300 mm 
thick slices with a vibratome in ice cold Ringer’s solution. Slices were then placed in 
room temperature oxygenated Ringer’s solution and allowed to equilibrate for one hour.  
Whole-cell patch clamp recording 
Slices were placed in a submersion recording chamber (Harvard Apparatus, 
Holliston, MA) on a Nikon E600 infrared-differential interference contrast (IR-DIC) 
microscope (Micro Video Instruments, Avon, MA). Slices were secured by a nylon mesh 
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and bathed in continual flow of oxygenated Ringer’s solution. Medium spiny neurons 
(MSNs) of the dorsolateral striatum were filled with 0.5% biocytin during whole-cell 
patch clamp recordings. Pipettes were filled with potassium methane sulfonate internal 
solution (in mM: 122 KCH3SO3, 2 MgCl2, 0.2 EGTA, 10 NaHEPES, 5 MgATP and 0.5% 
biocytin) and had a resistance of 5-7 MOhms. Electrophysiology was performed using 
HEKA EPC-9 or EPC-10 amplifiers and Patch Master software (HEKA Elektronik, 
Lambrecht, Germany). Experiments measured passive membrane properties, action 
potential properties and spontaneous excitatory and inhibitory postsynaptic currents 
(sEPSC and sIPSC, respectively), as described previously (ref).    
Preparation of slices containing filled neurons for confocal microscopic scanning 
The slices containing neurons filled with biocytin during recordings were 
transferred for overnight incubation into wells containing 4% PFA. Following the 
fixation period, the slices were rinsed 3 times in 0.1M phosphate buffered saline (PBS) 
solution for 10 minutes each and then bathed in a 1% Triton X-100 in PBS solution for 2 
hours. They were then incubated in an Alexa-streptavidin 568 solution (diluted 1:500 in 
PBS) for 2 days at 4 degrees Celsius. The slices were subsequently rinsed an additional 3 
times with 0.1M PBS and then stored at 4 degrees Celsius in a PBS-Azide solution. They 
were transferred into anti-freeze solution for prolonged storage. Before imaging, slices 
were mounted and cover slipped using prolong anti-fade mounting medium (Invitrogen), 
and allowed to cure in room temperature for about 1 week.  
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Confocal microscopic scanning 
A high-resolution Leica SPE Confocal Laser Scanning Microscopy (CLSM) was 
used to scan the neurons in order to visualize the dendrites. A UPlan-FL 40x 1.3 NA oil-
immersion objective lens was used. The biocytin filled neurons were scanned at a 
resolution of .26882 x .26882 x .5 um per voxel in order to be able to visualize the whole 
cell dendritic morphology. The red channel (Alexa Fluor 568) was imaged using a 560nm 
diode laser. 
Processing images before quantitative analyses 
The acquired images were deconvolved using the AutoQuant Software (Media 
Cybernetics, Bethesda, MD) in order to sharpen the image and decrease the intensity of 
the signal halo that is intrinsic in the z-plane during confocal imaging. Subsequently, the 
z-stack file was converted from a 16-bit to an 8-bit file.  
Dendrite Reconstruction 
The .tif files were imported into the NeuroLucida 360 neuron reconstruction 
software (MicroBrightField Bioscience), which was used to reconstruct the cell bodies 
and dendritic arbors of all 45 neurons. First, the volume of the soma was measured. 
Subsequently, the dendrites were traced using a semi-automated user guided setting 
beginning at the soma and moving distally. The files were imported into NeuroLucida 
version 11 for manual editing in order to ensure accuracy of the reconstruction. Nodal 
points and dendritic branches were manually reviewed in order to confirm precision.	
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Dendrite analysis 
 Quantitative data for the dendritic parameters of the reconstructed neurons was 
obtained using the software NeuroLucida Explorer software (MBF Bioscience). Specific 
morphological properties of the neurons were acquired including dendritic length, 
dendritic complexity, and size of the somata. A sholl analysis was completed with 
concentric rings placed 10mm apart, starting from the center of the soma, in order to 
determine the length of the dendrites and amount of branching as a function of distance 
from the center of the soma. A convex hull analysis was used to determine the volume of 
tissue spanned by the entire neuron.  
Statistical Analyses and Correlations 
All the data generated from NeuroLucida Explorer was exported to Microsoft Excel to be 
analyzed. The mean, standard deviation, and standard error were calculated in Microsoft 
Excel and used to create the graphs in this study. T-tests were used to determine the 
significant differences between groups, with a significance level set at 0.05. Finally, 
linear correlations, using Pearson’s correlation, between the electrophysiological and 
morphological data were made in Microsoft Excel.  
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RESULTS 
 Recordings and intracellular fillings of D1 and D2 MSNs were employed from 
wild type and Q175+/- mice, and D1 and D2 expression in each of the neurons were 
verified using confocal microscopy (Figure 8).  Both WT and Q175+/- mice were crossed 
with D2-eGFP mice, and thus somata of recorded D2 (indirect pathway MSNs) were 
labeled with green fluorescence, while unlabeled D2-negative MSNs were considered as 
D1 MSNs (Figure 8).  
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Figure 8: Morphological and electrophysiological features of D1 and D2 MSNs. A 
MSNs were filled with biocytin (red) and then tested for immunoreactivity with GFP 
(green) (Figure 9A). Direct pathway D1 MSNs are GFP-, while indirect pathway D2 
MSNs are GFP+. B Some of the electrophysiological parameters considered in our study, 
such as Rn, Rheobase, sEPSc frequency, and sEPSC amplitude.  
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Figure 9: Example of a 3D scan (left) and Sholl analysis (right) of an MSN. The 
image on the left is an example of a three-dimensional scan of an MSN scanned with the 
confocal microscope at 40x. The image on the right is an example of a Sholl analysis of 
an MSN with concentric rings around the soma at distances of 10µm apart.  
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WT D1 MSNs 
                
      May5IR2a               Apr29IR2a    Apr29IR2b     May24IR2b              May9IR2a 
             
     Apr15IR2c            May9IR3b               May9IR3d    Apr12IR2a 
 
WT D2 MSNs 
          
     Apr29IR3a          Apr26IR3h             Apr12IR1b 
 
Q175+/- D1 MSNs 
              
       Apr25IR2a           Apr25IR2c  May6IR2f    Apr27IR3h       May4IR2fo 
             
      May16IR2d             May4IR2e  May4IR2f  Apr13IR2c                Apr13IR3b 
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Q175+/- D2 MSNs 
           
     Apr25IR2b          May6IR2e              May2IR3e                 May6IR3c    May4IR2a 
            
       May4IR2b            Apr27IR3d              Apr27IR3g  Apr27IR3i    Apr27IR2d 
           
       Apr27IR2b            May16IR2e             Apr20IR2a               Apr20IR2b   Apr20IR2c 
            
      Apr20IR3a          Apr20IR3b           Apr15IR2b              Apr15IR2d   Apr15IR2g 
      
     Apr15IR2h          Apr15IR2i                Apr13IR2b 
Figure 10: Three-dimensional reconstructions of all the MSNs included in the study.  
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Dendritic topology of WT and Q175+/- MSNs 
D1 and D2 MSNs included in this study were reconstructed in three-dimensions 
(3D) using confocal image stacks acquired at 40x magnification (Figures 9 and 10). The 
Q175+/- D1 MSNs had a significantly larger total dendritic length than their WT 
counterparts (Figure 11A; 3116  ± 197and 2031 ± 208 µm; p=0.001). By contrast, 
Q175+/- D2 MSNs had similar total dendritic lengths to WT D2 MSNs (Figure 11A). In 
addition, total dendritic lengths of WT D1 and D2 MSNs were comparable. However, 
Q175+/- D1 MSNs had significantly longer total dendritic lengths than Q175+/- D2 
MSNs (Figure 11A; 3116 ± 197 and 2136  ± 97µm; p=.0004). Dendritic length 
determined by Sholl analysis revealed that Q175+/- D1 MSNs had significantly longer 
dendritic lengths compared to WT D1 MSNs specifically in the proximal part of the arbor 
located 20µm-100µm away from the soma (Figure 11B; p < 0.05). At all other distances, 
dendritic lengths did not differ. At a distance of 20µm-60µm away from the soma, WT 
D2 MSNs had significantly longer dendritic lengths than their Q175+/- counterparts 
(Figure 11C; p<0.05). In contrast, Q175+/- D2 MSNs had significantly longer dendritic 
lengths 20µm away from the soma compared to WT D2 MSNs (Figure 11C; p=0.05). 
Dendritic lengths were similar between indirect pathway WT and Q175+/- MSNs at all 
other distances from the soma. Furthermore, the Sholl analysis also revealed that WT D2 
MSN dendritic lengths were significantly longer than WT D1 MSNs at distances 30µm -
60µm away from the soma (Figure 11D; p<0.05). On the other hand, at a distance of 
120, 130, and 150µm away from the soma, WT D1 MSN dendritic lengths were 
significantly longer than WT D2 MSNs (Figure 11D; p<0.05). Their dendritic lengths 
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were similar at all other distances from the soma (Figure 11D). Finally, we observed that 
Q175+/- D1 MSNs had longer dendritic lengths than Q175+/- D2 MSNs at distances 30-
120µm away from the soma (Figure 11E; p < 0.05). 
  
	37 
 
 
 
 
 
 
 
Figure 11: Total dendritic length and dendritic length by distance from the soma of 
WT and Q175+/- direct and indirect pathway MSNs. A, box and whisker plot of total 
dendritic length of WT and Q175+/- D1 and D2 MSNs. B, C, D, E, Sholl Analysis of 
dendritic length by distance from the soma. 
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Dendritic complexity of the MSNs was determined via Sholl analysis by number 
of dendrite crossings (intersections) at each Sholl ring from the soma (Figure 10). The 
total number of intersections was larger for D1 Q175+/- MSNs compared to their WT 
counterparts (Figure 12A; 251 ± 50 and 169 ± 66µm; p=0.008). By contrast, D2 Q175+/- 
MSNs had a similar total number of intersections than WT D2 MSNs (Figure 12A). 
When comparing the total number of intersections within the group of Q175+/- mice, we 
found that D1 MSNs had significantly larger numbers of intersections than D2 MSNs 
(Figure 12A; 251 ± 50 and 172 ± 48µm; p=0.001). However, the total number of 
intersections was comparable in WT D1 and D2 MSNs. The Sholl analysis revealed that 
Q175+/- D1 MSNs had a significantly larger number of intersections starting from a 
distance of 20µm to 90µm away from the soma compared to WT D1 MSNs (Figure 12B; 
p < 0.05). Their dendritic complexities were comparable at all other distances from the 
soma. In addition, WT D2 MSNs had a significantly larger number of intersections at 
40µm and 60µm away from the soma compared to Q175+/- D2 MSNs (Figure 12C; p < 
0.05). In contrast, Q175+/- D2 MSNs had significantly more intersections than WT D2 
MSNs at 110µm and 120µm  away from the soma (Figure 12C; p < 0.05). Their dendritic 
complexities were similar at all other distances from the soma. Furthermore, at 40−60µm 
away from the soma, WT D2 MSNs had a larger number of intersections than their D1 
counterparts (Figure 12D; p < 0.05). But at distances 110-130µm, WT D1 MSNs had 
more intersections than WT D2 MNSs (Figure 12D; p < 0.05). Dendritic complexity was 
comparable between WT D1 and D2 MSNs at all distances from the soma (Figure 12D). 
	39 
Finally, Q175+/- D1 MSNs had significantly larger numbers of intersections at 20µm to 
100µm away from the soma compared to their D2 counterparts (Figure 12E; p < 0.05).   
We also analyzed these morphological parameters by gender, and found no 
significant differences in dendritic length or complexity between female and male mice in 
both the WT and Q175+/- conditions (data not shown). The differences that were found 
within the female and male WT and Q175+/- groups paralleled the observations stated 
above, suggesting no morphological gender differences between D1 and D2 MSNs.  
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Figure 12: Total dendritic complexity and dendritic complexity measured via Sholl 
analysis of WT and Q175+/- direct and indirect pathway MSNs. A, Box and whisker 
plot of the total dendritic complexity and WT and Q175+/- direct and indirect pathway 
MSNs. B, C, D, E, dendritic complexity Sholl analysis.    
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The mean number of primary branches was calculated in Microsoft Excel. 
Q175+/- D1 MSNs had a significantly larger mean number of primary branches than WT 
D1 MSNs (Figure 13; 7±.683 and 4.89±.423µm; p =0.019). There was no significant 
difference found between the mean number of primary branches of WT and Q175+/- D2 
MSNs, WT D1 and D2 MSNs, or Q175+/- D1 and D2 MSNs (Figure 13). Furthermore, 
no significant differences in mean maximal branch order was observed between WT and 
Q175+/- direct and indirect pathway MSNs (data not shown). 
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Figure 13: Mean number of primary branches in WT and Q175+/- direct and 
indirect pathway MSNs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	43 
Electrophysiological and Morphological Correlations 
 We correlated certain electrophysiological parameters, including Rn, rheobase, 
EPSC frequency, and EPSC amplitude, with the morphological data obtained from the 
same 9 WT and 23 Q175+/- MSNs. As shown in figure 14, no significant correlation was 
found between total dendritic length and Rn, rheobase, EPSC frequency, or EPSC 
amplitude in WT or Q175+/- MSNs assessed separately (Figure 14A, C, D, F) or 
combined (Figure 14B, D, F, H; n=32). Likewise, we also correlated the aforementioned 
electrophysiological properties with the dendritic complexities of the same WT and 
Q175+/- MSNs and found no significant correlations, except a significantly positive 
correlation between rheobase and total number of intersections in the combined group of 
MSNs (Figure 15D, p < 0.05).  
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Figure 14: Correlations of various electrophysiological parameters and total 
dendritic length.  
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Figure 15: Correlations of various electrophysiological parameters and dendritic 
complexity. 
	46 
          
 
Correlations: Rn v. Total Dendritic 
Length 
 
Correlations: Rn v. Total 
Intersections 
 
  R p DF 
 
  R p DF 
 
WT 0.539 p > 0.1 7 
 
WT 0.6347 p > 0.1 7 
 
Q175+/- 0.0095 p > 0.1 21 
 
Q175+/- 0.0283 p > 0.1 21 
 
Combined 0.1152 p > 0.1 30 
 
Combined 0.2238 p > 0.1 30 
          
 
Correlations: Rheobase v. Total
Dendritic Length 
 
Correlations: Rheobase v. Total 
Intersections 
 
  R p DF 
 
  R p DF 
 
WT 0.5461 p > 0.1 6 
 
WT 0.6835 p > 0.1 6 
 
Q175+/- 0.1833 p > 0.1 14 
 
Q175+/- 0.2598 p > 0.1 14 
 
Combined 0.333 p > 0.1 22 
 
Combined 0.4792 
p < 
0.05 22 
          
 
Correlations: EPSC Frequency v. 
Total Dendritic Length 
 
Correlations: EPSC Frequency v. 
Total Intersections 
 
  R p DF 
 
  R p DF 
 
WT 0.1072 p > 0.1 5 
 
WT 0.5437 p > 0.1 6 
 
Q175+/- 0.557 p > 0.1 9 
 
Q175+/- 0.5463 p > 0.1 9 
 
Combined 0.4234 p > 0.1 16 
 
Combined 0.0346 p > 0.1 17 
          
 
Correlations: EPSC Amplitude v. 
Total Dendritic Length 
 
Correlations: EPSC Amplitude v. 
Total Intersections 
 
  R p DF 
 
  R p DF 
 
WT 0.4254 p > 0.1 5 
 
WT 0.0014 p > 0.1 6 
 
Q175+/- 0.5235 0.05 < p < 0.1 9 
 
Q175+/- 0.5666 p > 0.1 9 
 
Combined 0.2287 p > 0.1 16 
 
Combined 0.2565 p > 0.1 17 
      
 
 
 
 
 
 
 
 
 
 
   Figure 16: Comprehensive data tables of R-values, p-values, and degrees of freedom 
for each of the correlations. 
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DISCUSSION 
 There has been some controversy in the scientific literature as to whether D1 and 
D2 MSNs are a homogeneous population of cells in terms of both their 
electrophysiological and morphological properties. The present study examined the 
morphological properties of WT and Q175+/- direct and indirect pathway MSNs and 
correlated it with their electrophysiological properties. Three-dimensional reconstruction 
of biocytin-filled MSNs followed by Sholl analysis revealed that Q175+/- D1 MSNs had 
significantly larger total dendritic lengths and more complex dendritic arbors than their 
WT counterparts. The more extensive dendritic arbor of D1 MSNs affected with HD may 
indicate that they also have additional synaptic connections as a result of an extended 
postsynaptic surface (Elburg & Ooyen, 2010). These findings suggest a compensatory 
effect in HD-affected D1 MSNs, leading to structural changes such as an increase in 
dendritic length and possibly the number of glutamatergic synapses they receive as a 
result. Consistent with these findings, Q175+/- D1 MSNs also had a larger mean number 
of primary dendrites than WT D1 MSNs.  
Moreover, it has been established that dendritic length and branching pattern of 
the dendritic arbor can affect the degree of summation of synaptic inputs, as well as the 
quality of input signal filtering (Luebke, 2017). Thus, since Q175+/- D1 MSNs have 
significantly longer dendritic lengths than their D2 counterparts, we can predict that they 
filter input signals to a greater extent; assuming that both cell types have similar dendritic 
diameters. In addition, dendritic length and branching pattern also significantly influence 
burst firing, which is a critical firing pattern observed in neuronal signaling (Elburg & 
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Ooyen, 2010). Burst firing refers to the generation of a narrowly spaced succession of 
two or more action potentials, and can play a role in transmitting specific information 
related to sensory stimuli, as well as inducing synaptic long-term potentiation, an 
important mechanism underlying learning and memory (Elburg & Ooyen, 2010). Thus, 
since Q175+/- D1 MSNs experience an increase in dendritic length compared to WT D1 
MSNs, this leads to a change in burst firing pattern and ultimately affecting cognition.  
Interestingly, this same pattern was not observed in D2 MSNs. We found that 
Q175+/- D2 MSNs had similar total dendritic lengths, dendritic complexities, and mean 
number of primary branches as their WT counterparts. This finding suggests that the 
same compensatory effect is not experienced by D2 MSNs; however, this absence of 
increased dendritic length may also have been due to the low number of WT D2 MSNs 
(n=3) included in the study compared to Q175+/- D2 MSNs (n=23).  
 Furthermore, WT D1 and D2 MSNs were similar in terms of their total dendritic 
length and total number of intersections, suggesting a degree of homogeneity in these 
cells specifically in their topological features. Our results differ from those found by 
Gertler and colleagues (2008), who stated that there is a dichotomy in the dendritic 
anatomy of MSNs, arguing that WT D1 MSNs had significantly greater total dendritic 
lengths and dendritic arbors than WT D2 MSNs.  However, like Huerta-Ocampo and 
colleagues (2014), we also observed no difference in mean number primary dendrites 
between WT D1 and D2 MSNs, again suggesting a morphological consistency between 
the two cell populations.  
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 Additionally, we found that the presence of expanded CAG repeats (such as is 
seen in Huntington’s disease) differentially affects the two groups of MSNs. For 
example, Q175+/- D1 MSNs had a significantly larger total dendritic length and number 
of intersections than Q175+/- D2 MSNs. This signifies that excess CAG affects D1 
MSNs to a greater extent than D2 MSNs. However, as mentioned previously the low 
number of WT D2 MSNs included in the analysis may have skewed the accuracy of the 
results.  
 Furthermore, previous studies have not directly correlated electrophysiological 
and morphological parameters. Changes in dendritic topology generally did not occur in 
parallel with electrophysiological changes in the MSNs. Our study found no correlations 
between membrane resistance, rheobase, EPSC frequency, or EPSC amplitude, and total 
dendritic length or dendritic complexity of MSNs when observed separately (WT and 
Q175+/-) or combined, with one exception. When observing the group of MSNs as a 
whole, we found a positive correlation between rheobase and total intersections. This 
finding indicates that electrophysiological changes may not be causing the subsequent 
morphological changes observed in HD affected MSNs, thus alternate mechanisms must 
be explored.  
 Further studies should include a larger number of cells, specifically WT D2 
MSNs. In addition, further inspection of electrophysiological parameters on D1 versus 
D2 MSNs should be considered. Finally, electrophysiological factors such as inhibitory 
synaptic current properties, as well as morphological properties like spine density should 
be measured in order to have a more complete picture of the effects of HD on MSNs. 
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